Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
DDGP(cisplatin,dexamethasone,gemcitabine,pegaspargase)
DRUG
2 trials
Sponsors
Mingzhi Zhang
Conditions
Nasal and Nasal-type NK/T-cell Lymphoma
Phase 4
Treatment of Natural Killer/T Cell Lymphoma-I/II
NCT01501136
Mingzhi Zhang
Nasal and Nasal-type NK/T-cell Lymphoma
Start: 2011-01-31
End: 2019-05-31
Target: 200
Updated: 2015-07-17
Treatment of Natural Killer/T Cell Lymphoma-Ⅲ/Ⅳ
NCT01501149
Mingzhi Zhang
Nasal and Nasal-type NK/T-cell Lymphoma
Start: 2011-01-31
End: 2019-05-31
Target: 80
Updated: 2015-07-17
Related Papers
Efficacy and Safety of a Pegasparaginase-Based Chemotherapy Regimen vs an L-asparaginase–Based Chemotherapy Regimen for Newly Diagnosed Advanced Extranodal Natural Killer/T-Cell Lymphoma
JAMA Oncology
2022-06-16
55 citations
Radiotherapy vs sequential pegaspargase, gemcitabine, cisplatin and dexamethasone and radiotherapy in newly diagnosed early natural killer/T‐cell lymphoma: A randomized, controlled, open‐label, multicenter study
International Journal of Cancer
2020-10-09
15 citations
Efficacy and Survival in Newly Diagnosed Advanced Extranodal Natural Killer/T-Cell Lymphoma: A Randomized, Controlled, Multicenter and Open-Labled Study with Ddgp Regimen Versus SMILE Regimen
Blood
2019-11-13
15 citations
<p>Clinical efficacy of cisplatin, dexamethasone, gemcitabine and pegaspargase (DDGP) in the initial treatment of advanced stage (stage III&ndash;IV) extranodal NK/T-cell lymphoma, and its correlation with Epstein-Barr virus</p>
Cancer Management and Research
2019-04-01
18 citations
Efficacy and safety of cisplatin, dexamethasone, gemcitabine and pegaspargase (DDGP) regimen in newly diagnosed, advanced-stage extranodal natural killer/T-cell lymphoma: interim analysis of a phase 4 study NCT01501149
Oncotarget
2016-06-17
17 citations
DDGP versus SMILE in Newly Diagnosed Advanced Natural Killer/T-Cell Lymphoma: A Randomized Controlled, Multicenter, Open-label Study in China.
2016-04-08
109 citations